- Q4 2023 CorMedix Inc Earnings Call TranscriptMar 12, 2024€3.1 (-3.73%)Earnings
- Q3 2023 CorMedix Inc Earnings Call TranscriptNov 14, 2023€2.86 (+2.88%)Earnings
- CorMedix Inc at HC Wainwright Investment Conference - New York TranscriptSep 13, 2023
- Q2 2023 CorMedix Inc Earnings Call TranscriptAug 08, 2023€3.64 (-2.67%)Earnings
- CorMedix Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- CorMedix Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- CorMedix Inc at JMP Securities Life Sciences Conference TranscriptMay 16, 2023
- Q1 2023 CorMedix Inc Earnings Call TranscriptMay 15, 2023€4.56 (-5.39%)Earnings
- Q4 2022 CorMedix Inc Earnings Call TranscriptMar 30, 2023€3.4 (+9.57%)Earnings
- Q3 2022 CorMedix Inc Earnings Call TranscriptNov 10, 2022€2.77 (-3.04%)Earnings
- Q2 2022 CorMedix Inc Earnings Call TranscriptAug 11, 2022€3.28 (+6.18%)Earnings
- CorMedix Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- Q1 2022 CorMedix Inc Earnings Call TranscriptMay 12, 2022€2.98 (-5.24%)Earnings
- Q4 2021 CorMedix Inc Earnings Call TranscriptMar 29, 2022€5 (-8.26%)Earnings
- CorMedix Inc Annual Shareholders Meeting TranscriptDec 09, 2021
- Q3 2021 CorMedix Inc Earnings Call TranscriptNov 09, 2021€4.48 (-0.44%)Earnings
- Q2 2021 CorMedix Inc Earnings Call TranscriptAug 12, 2021€4.86 (-2.80%)Earnings
- Q1 2021 CorMedix Inc Earnings Call TranscriptMay 13, 2021€6.25 (-5.30%)Earnings
- Q4 2020 CorMedix Inc Earnings Call TranscriptMar 30, 2021€7.2 (+0.70%)Earnings
- CorMedix Inc. - Special Call TranscriptMar 09, 2021
- CorMedix Inc Annual Shareholders Meeting TranscriptDec 16, 2020
- Q3 2020 CorMedix Inc Earnings Call TranscriptNov 05, 2020€4.5Earnings
- Q2 2020 CorMedix Inc Earnings Call TranscriptAug 10, 2020€3.66 (-0.54%)Earnings
- CorMedix Inc. - Special Call TranscriptMay 19, 2020
- Q1 2020 CorMedix Inc Earnings Call TranscriptMay 11, 2020€3.8 (+6.15%)Earnings
- Q4 2019 CorMedix Inc Earnings Call TranscriptMar 16, 2020€3.44 (+0.58%)Earnings
- Q3 2019 CorMedix Inc Earnings Call TranscriptNov 14, 2019€4.8 (+2.13%)Earnings
- Q2 2019 CorMedix Inc Earnings Call TranscriptAug 13, 2019€7.19 (-2.57%)Earnings
- Q1 2019 CorMedix Inc Earnings Call TranscriptMay 13, 2019Earnings
CorMedix Inc at JMP Securities Life Sciences Conference Transcript
Good afternoon, everybody. I am Joe Todisco; I'm the newly appointed CEO of CorMedix. I'm excited to be wrapping up my first month in seat.
I do believe that CorMedix is an attractive investment opportunity and that DefenCath, our lead product, will address a critical unmet medical need.
DefenCath is a catheter lock solution comprising heparin and taurolidine that we are developing for the reduction of catheter-related bloodstream infections. Our initial indication will focus on catheterized hemodialysis patients. But we do believe there will be broad applications across multiple therapeutic areas where catheters are utilized in patients.
Catheter-related bloodstream infections are a substantial burden in the US healthcare system, particularly in catheterized hemodialysis patients where the annual cost to the system in additional medical expenses is over $2.3 billion per year.
Between a quarter and a third of hemodialysis patients will have a CRBSI within the first 12 months of receiving hemodialysis via a catheter. The cost to treat
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)